is pleased to have had NeuroQuant and LesionQuant featured in several posters at both ASNR 2017 (Long Beach) and AAN 2017 (Boston).’ fast, accurate and proven quantitative imaging solutions are the first FDA cleared and CE marked software that provides radiologists and neurologists with quantifiable, volumetric data for brain atrophy (NeuroQuant) and lesion evolution (LesionQuant). Links to the abstracts are below.

Contact us to learn how neurologists, radiologists and researchers worldwide are using automated quantitative analysis to more objectively analyze brain MRIs.

ASNR 2017

Amygdala and Hippocampal Enlargement in Temporal Lobe Epilepsy

Imaging Temporal Lobe Epilepsy: Beyond the Hippocampus

Testing the Statistical Agreement of Automated NeuroQuant Brain Volumetric Analysis to SIENAX Across Multiple MRI Scanner Manufacturers and Field Strengths

Automatic Quantification of Lesion Burden in Patients With Multiple Sclerosis Using LesionQuant Software; Assessment of Feasibility and Clinical Application

Decreased Hippocampus and Amygdala Volumes in Patients with Traumatic Brain Injury Are Associated with Decreased Post-traumatic Stress Disorder Resilience

AAN 2017

NeuroQuant® in clinical practice: longitudinal observations and platform reliability and performance

Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant